NMN 175 mg by California Gold Nutrition — Ingredients, Evidence & Safety

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Beta-Nicotinamide Mononucleotide: 175mg is 5.0× the Tolerable Upper Intake Level (35mg)

The supplement contains 175mg of Beta-Nicotinamide Mononucleotide, which is five times the recommended maximum daily intake level of 35mg.

Label Data

1 Capsule(s) Serving Size

60 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Beta-Nicotinamide Mononucleotide

175 mg

⚠️ Exceeds Tolerable Upper Intake Level by 5.0× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)

RDA 14mg This product: 175mg UL 35mg

Other Ingredients

Gum Arabic Microcrystalline Cellulose Modified Cellulose Stearic Acid Magnesium Stearate Silicon Dioxide

Label Claims — Verification

❓ All Other

All Other (100% of products) Structure/Function (90% of products) Nutrient (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested Use: Take 1 capsule daily, without food. Best when taken as directed by a qualified healthcare professional.

⚠️ Warnings & Precautions

Warnings: Keep out of reach of children.

Consult with a licensed physician, pharmacist, naturopath or other qualified healthcare professional prior to taking dietary supplements. Sealed for your protection. Do not use if seal is missing or broken.

This product is not manufactured with milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soy, sesame, or gluten. Produced in an FDA registered, third-party audited, and cGMP-compliant facility that may process other products that contain these allergens or ingredients.

🧪 Formulation Notes

Nicotinamide Mononucleotide

Formulated without Gluten GMOs Soy

This product is not manufactured with milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soy, sesame, or gluten.

Additional Information

Store in a cool, dry place. Protect from heat, light, and moisture.

Product Details

UPC / SKU 8 98220 01920 5

DSLD Entry Date 2023-11-22

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand California Gold Nutrition

DSLD ID 299661

Data Updated 2026-04-11

Research Evidence

8 Research Sources

54 Avg Quality Score

4 Rct

2 Meta Analysis

2 Clinical Trial

B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials

Meta Analysis Critical reviews in food science and nutrition 2025

PubMed DOI

B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study

Rct GeroScience 2024

PubMed DOI

C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.

Rct Science (New York, N.Y.)

PubMed DOI

C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.

Rct GeroScience

PubMed DOI

C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials

Meta Analysis Current diabetes reports 2024

PubMed DOI

C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial

Rct Scientific reports 2023

PubMed DOI

C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.

Clinical Trial ClinicalTrials.gov 2021

ClinicalTrials.gov

C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function

Clinical Trial ClinicalTrials.gov 2017

ClinicalTrials.gov

View all evidence for Nmn →